Statin therapy associated Lactobacillus intestinalis attenuates pancreatic fibrosis through remodeling intestinal homeostasis
Authors:
Open Access
- 15 April 2025
- journal article
- research article
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 11 (1) , 1-15
Abstract
Chronic pancreatitis (CP) is characterized by irreversible fibrotic destruction and impaired pancreatic function. CP disrupts lipid metabolism and causes the imbalance of gut microbiota which in turn exacerbates pancreatic fibrosis. Statins alter gut microbiota and exert anti-inflammatory effects, but its role in CP has not been fully elucidated. Here, we found that statins-associated higher abundance of Lactobacillus intestinalis (L.intestinalis) maintained gut homeostasis that restrained bacteria translocation from gut to the pancreas, which eventually aggravated pancreatic fibrosis through inhibiting CD8+T cells-dependent immunity. Fecal microbiota transplantation (FMT) or L.intestinalis administration inhibited the infiltration of CD8+T cells and macrophages that delayed CP progression. L.intestinalis restrained the recruitment of M1 macrophages and limited the release of Ccl2/7 in the colon, which prevented epithelial damage and epithelial barrier dysfunction through blocking Ccl2/7-Ccr1 signaling. Our findings elucidate that the utilization of statin therapy or supplementation of L.intestinalis can be potential approach for the therapies of CP.Keywords
Funding Information
- National Natural Science Foundation of China (82270665, 82270666)
This publication has 54 references indexed in Scilit:
- Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of AutophagyMolecular Cancer Therapeutics, 2016
- Complement Component 5 Mediates Development of Fibrosis, via Activation of Stellate Cells, in 2 Mouse Models of Chronic PancreatitisGastroenterology, 2015
- Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitisNature Communications, 2015
- Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel DiseasesIntestinal Research, 2015
- Regulation of the Immune System by the Resident Intestinal BacteriaGastroenterology, 2014
- Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling PathwayInternational Journal of Molecular Sciences, 2013
- Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cellsJournal of Hepatology, 2010
- Chronic Pancreatitis Is Associated With Disease-Specific Regulatory T-Cell ResponsesGastroenterology, 2010
- A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosisGut, 2005
- Cytokine mRNA Levels and Lymphocyte Infiltration in Pancreatic Tissue During Experimental Chronic Pancreatitis Induced by Dibutyltin DichlorideDigestive Diseases and Sciences, 2001